Drug survival of biologic treatments in psoriasis: a systematic review
Drug survival measures the length of time until discontinuation of a drug. The length of time a patient remains on a biologic drug is impacted by several factors such as tolerability, side effects, safety profile and effectiveness. To evaluate the long-term drug survival, data of the most commonly p...
Main Authors: | Daniel J. No, Megan S. Inkeles, Mina Amin, Jashin J. Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2018-07-01
|
Series: | Journal of Dermatological Treatment |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/09546634.2017.1398393 |
Similar Items
-
Ustekinumab Drug Survival in Patients with Psoriasis: A retrospective Study of Real Clinical Practice
by: Cristina Galache Osuna, et al.
Published: (2020-10-01) -
A retrospective observational study on biological drug treatment in a daily practice serving patients with psoriasis in Japan
by: Chika Ohata, et al.
Published: (2019-01-01) -
Effectiveness and safety of ustekinumab for the treatment of psoriasis; six years of clinical experience
by: Melis Gönülal, et al.
Published: (2023-12-01) -
Generalised pustular psoriasis – a case report and review of therapeutic approaches
by: Agnieszka Osmola-Mańkowska
Published: (2014-11-01) -
Rates of latent tuberculosis infection in patients treated with TNF inhibitors for psoriasis: a retrospective chart review
by: Erica B. Lee, et al.
Published: (2018-10-01)